Apeloa Pharmaceutical Co Ltd

Apeloa Pharmaceutical Co Ltd

000739 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

19.51CNY-0.90 (-4.41%)

Price History

Full chart

Market Stats

Previous Close20.41
Open20.35
Day Range19.41 – 20.37
52-Week Range14.70 – 27.89
Volume9.80M
Market Cap32.14B
P/E (TTM)37.49
Forward P/E0.00
EPS0.74
Dividend Yield1.36%
Beta0.23
50-Day Avg22.25
200-Day Avg18.77

About

Apeloa Pharmaceutical Co.,Ltd provides raw materials various pharmaceutical factories in the People's Republic of China and internationally. The company operates through API, CDMO, and Pharmaceutical segments. It offers API intermediates business, which includes cephalosporin, penicillin, psychotropic, cardiovascular and cerebrovascular, and veterinary API intermediates series; innovative drug R&D and production services CDMO include R&D services, commercial human drug projects, commercial veterinary drug projects and other commercial projects; pharmaceutical business includes anti-infective, cardiovascular, psychotropic, hepatobiliary and anti-tumor categories. The company also provides technology platforms, such as flow chemistry, synthetic biology and biocatalysis, crystallization and particle engineering, peptide, high potency compound, conjugate library service, oligonucleotide synthesis, and preparation and purification; and controlled-release formulation development, taste masking technology, and particle flow simulation. In addition, it exports its products under the Tianliwei, Baishixin, Li'an, Jutai, and other brands. Apeloa Pharmaceutical Co.,Ltd was founded in 1989 and is based in Dongyang, the People's Republic of China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Fangmeng Zhu
  • Employees6.79K
  • HeadquartersNo.399 Jiangnan Road, Dongyang, China, 322118, China
  • Websitehttps://www.apeloa.com

Leadership

  • Mr. Fangmeng ZhuCEO & Chairman · b. 1972
  • Mr. Chun HePresident & Head of ACI BU · b. 1974
  • Mr. Min JinSenior Vice President · b. 1968
  • Mr. Lei CaiSenior Vice President & Head of CDMO BU · b. 1979
  • Mr. Yuwang ZhouVice President & Secretary · b. 1966
  • Mr. Lihua WuChief Financial Officer
  • Mr. Hui ZhangChief Technology Officer
  • Mr. Yonglong LiHead of API BU
  • Mr. Liang YuHead of FDF BU

Financials

Income Statement

Currency: CNY1994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue331.16M344.32M368.68M367.70M418.09M225.65M178.82M141.84M659.33M770.25M830.52M1.04B1.18B1.04B1.23B1.37B1.52B2.81B3.48B3.86B4.23B4.34B4.77B5.55B6.38B7.21B7.88B8.94B10.54B11.47B12.02B9.76B
Growth (%)-+3.97%+7.08%-0.27%+13.70%-46.03%-20.75%-20.68%+364.85%+16.82%+7.82%+24.67%+14.37%-12.05%+17.92%+11.38%+11.20%+84.99%+23.69%+10.78%+9.79%+2.48%+10.01%+16.34%+14.85%+13.09%+9.28%+13.49%+17.92%+8.81%+4.77%-18.82%
Cost of Revenue288.03M294.64M313.64M313.12M366.31M187.10M156.57M130.74M511.02M611.25M671.38M833.38M921.23M845.83M993.25M1.07B1.20B2.25B2.69B2.99B3.15B3.18B3.47B3.87B4.37B4.91B5.70B6.58B8.08B8.62B9.23B7.38B
Gross Profit43.13M49.68M55.04M54.58M51.78M38.54M22.25M11.09M148.32M159.00M159.14M202.03M227.33M195.69M234.88M298.93M319.86M560.12M786.18M864.85M1.08B1.16B1.31B1.69B2.01B2.30B2.18B2.36B2.47B2.85B2.80B2.37B
Gross Margin13.02%14.43%14.93%14.84%12.39%17.08%12.44%7.82%22.50%20.64%19.16%19.51%19.20%18.79%19.13%21.85%21.03%19.91%22.59%22.43%25.59%26.66%27.35%30.36%31.50%31.91%27.66%26.43%23.42%24.86%23.26%24.33%
Operating Expense29.03M31.34M35.08M23.47M42.89M29.66M18.25M36.14M98.43M108.28M88.71M122.15M165.97M170.33M169.47M231.65M250.54M407.73M550.14M679.36M739.97M954.30M1.01B1.35B1.52B1.66B1.21B1.24B1.46B1.63B1.58B1.50B
Operating Income14.10M18.34M19.96M31.11M8.89M8.89M4.00M-25.05M49.89M50.72M70.43M79.88M61.36M25.36M65.41M67.28M69.32M152.39M236.04M185.48M343.07M202.34M299.94M335.69M490.53M644.15M969.71M1.12B1.01B1.22B1.21B878.92M
Operating Margin4.26%5.33%5.41%8.46%2.13%3.94%2.24%-17.66%7.57%6.58%8.48%7.72%5.18%2.43%5.33%4.92%4.56%5.42%6.78%4.81%8.11%4.66%6.29%6.05%7.69%8.93%12.31%12.52%9.59%10.63%10.08%9.01%
EBITDA11.80M16.19M19.27M25.20M17.64M4.80M7.51M-12.82M94.86M97.09M104.20M119.64M156.01M121.22M128.63M156.23M130.37M328.38M429.37M451.82M578.27M531.55M576.51M704.68M749.99M957.00M1.17B1.32B1.30B1.63B1.58B1.56B
EBITDA Margin3.56%4.70%5.23%6.85%4.22%2.13%4.20%-9.04%14.39%12.60%12.55%11.55%13.17%11.64%10.47%11.42%8.57%11.67%12.34%11.72%13.66%12.25%12.08%12.69%11.76%13.27%14.82%14.74%12.29%14.21%13.11%15.95%
Net Income10.56M12.99M14.22M23.00M4.05M7.63M-3.40M-25.87M31.59M34.19M35.63M43.75M53.31M30.44M29.06M34.09M23.79M75.63M137.13M167.36M322.16M208.23M262.90M256.59M370.56M553.40M816.73M955.55M989.17M1.06B1.03B890.68M
Net Income Margin3.19%3.77%3.86%6.26%0.97%3.38%-1.90%-18.24%4.79%4.44%4.29%4.23%4.50%2.92%2.37%2.49%1.56%2.69%3.94%4.34%7.61%4.80%5.51%4.62%5.81%7.67%10.37%10.69%9.38%9.20%8.58%9.13%
R&D----------------47.95M71.94M105.62M109.71M166.21M183.24M210.14M259.18M269.65M359.89M350.06M446.22M532.92M624.87M641.47M517.80M
R&D as % of Total Revenue----------------3.15%2.56%3.03%2.85%3.93%4.22%4.40%4.67%4.23%4.99%4.44%4.99%5.05%5.45%5.34%5.31%
Interest Expense2.01M4.38M5.08M849.99K1.57M2.83M6.26M8.59M16.42M13.48M17.83M23.73M33.69M37.55M34.83M36.18M37.67M82.47M107.57M82.07M83.82M68.35M64.10M62.79M42.98M31.78M17.81M37.96M63.50M47.23M35.55M27.83M
Interest Expense % of Total Revenue0.61%1.27%1.38%0.23%0.38%1.26%3.50%6.06%2.49%1.75%2.15%2.29%2.84%3.61%2.84%2.65%2.48%2.93%3.09%2.13%1.98%1.58%1.34%1.13%0.67%0.44%0.23%0.42%0.60%0.41%0.30%0.29%

Balance Sheet

Currency: CNY1994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets141.51M146.29M164.37M392.71M453.48M520.33M452.01M587.38M689.28M863.07M1.11B1.14B1.26B1.61B1.74B1.75B1.84B3.63B4.11B4.66B5.06B5.39B5.62B5.69B5.75B6.52B7.49B9.04B12.02B12.77B12.73B12.32B
Total Liabilities106.16M98.50M114.25M171.26M227.17M212.40M177.79M327.67M395.59M534.24M743.40M732.94M828.68M864.02M973.00M954.91M1.04B2.40B2.74B2.80B2.76B2.98B3.00B2.64B2.41B2.75B3.10B3.98B6.50B6.54B5.98B5.97B
Total Equity35.35M47.79M50.12M221.45M225.50M306.24M272.94M247.07M278.66M305.57M334.00M372.30M396.94M713.61M742.67M771.62M790.27M1.21B1.35B1.79B2.31B2.42B2.62B3.05B3.35B3.77B4.39B5.06B5.51B6.22B6.74B6.34B
Cash5.87M5.46M4.99M7.78M23.08M73.39M13.62M17.32M30.43M131.56M220.74M137.93M247.85M502.32M280.11M248.32M277.21M583.72M831.51M810.74M807.72M795.06M553.01M546.98M644.38M1.04B2.19B2.61B3.55B3.58B3.66B3.79B
Total Debt55.35M35.38M36.00M20.00M34.00M86.00M117.01M194.21M224.71M313.21M492.21M473.21M443.06M459.21M500.21M420.21M495.71M1.07B1.26B1.32B885.77M1.15B1.20B1.11B686.10M122.00M330.28M460.36M828.25M830.98M897.86M1.51B
Net Debt49.48M29.92M31.01M12.22M10.92M12.61M103.39M176.89M194.28M181.65M271.47M335.28M195.21M-43.11M220.10M171.89M218.50M489.27M425.77M504.70M78.05M357.70M646.08M565.98M41.72M-913.81M-1.86B-2.15B-2.72B-2.75B-2.76B-2.27B

Cash Flow

Currency: CNY1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow30.10M-20.52M7.08M-569.79K2.81M105.36M47.54M87.40M159.43M174.20M94.57M208.30M121.05M404.62M335.90M190.45M786.64M441.16M180.42M209.80M832.69M1.36B1.06B611.75M1.33B1.03B1.21B1.23B
Investing Cash Flow-16.41M598.11K-91.87M13.36M-35.60M-52.69M-64.43M-117.27M-52.10M-115.98M-347.88M-92.66M-136.49M-555.02M-327.11M-504.13M-471.65M-440.99M-299.76M-79.42M-178.98M-440.84M106.37M-515.39M-591.30M-676.42M-398.01M-418.79M
Financing Cash Flow1.62M70.23M25.02M-9.10M45.89M48.47M106.06M-52.95M2.59M196.25M31.11M-147.43M44.34M158.06M46.13M377.21M-323.85M42.62M47.33M-92.55M-593.74M-706.15M78.75M-204.32M-196.09M-301.86M-582.15M-607.09M
Capital Expenditure16.43M7.80M3.22M1.03M47.23M88.09M111.07M121.65M53.84M115.70M349.04M93.66M139.81M289.21M339.59M505.01M540.22M452.06M331.35M163.42M81.62M31.85M317.12M701.92M509.11M630.47M460.75M386.21M
Free Cash Flow13.66M-28.33M3.86M-1.60M-44.42M17.27M-63.52M-34.26M105.58M58.50M-254.47M114.64M-18.76M-107.47M-3.69M-314.56M246.42M-10.90M-150.93M46.38M751.07M1.33B742.41M-90.18M817.00M400.90M748.01M844.46M
Dividends Paid12.38M1.80M6.04M10.32M24.61M18.29M7.29M30.62M39.36M44.69M39.89M37.43M31.17M122.89M84.65M75.38M88.17M162.55M129.40M141.56M119.84M129.64M201.35M286.38M335.88M383.02M401.63M812.46M
FCF to OCF45.40%138.01%54.59%280.50%-1578.27%16.39%-133.61%-39.20%66.23%33.58%-269.09%55.04%-15.50%-26.56%-1.10%-165.17%31.33%-2.47%-83.66%22.10%90.20%97.66%70.07%-14.74%61.61%38.87%61.88%68.62%
Dividend Paid to FCF90.60%-6.35%156.30%-645.42%-55.40%105.94%-11.47%-89.37%37.28%76.40%-15.68%32.65%-166.12%-114.35%-2293.00%-23.96%35.78%-1490.88%-85.73%305.25%15.96%9.76%27.12%-317.58%41.11%95.54%53.69%96.21%

Earnings

Report DateMar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013May 28, 2014Aug 28, 2014Oct 14, 2014Feb 14, 2015Apr 29, 2015Aug 26, 2015Oct 29, 2015Mar 24, 2016Apr 29, 2016Aug 23, 2016Oct 27, 2016Mar 14, 2017Apr 25, 2017Aug 27, 2017Oct 16, 2017Mar 9, 2018Apr 10, 2018Aug 7, 2018Oct 25, 2018Mar 8, 2019Apr 22, 2019Jul 29, 2019Oct 17, 2019Mar 11, 2020Apr 17, 2020Aug 17, 2020Oct 21, 2020Mar 11, 2021Apr 19, 2021Aug 18, 2021Oct 21, 2021Mar 9, 2022Apr 26, 2022Jul 27, 2022Oct 19, 2022Mar 9, 2023Apr 17, 2023Aug 14, 2023Oct 18, 2023Mar 7, 2024Apr 17, 2024Aug 16, 2024Oct 17, 2024Mar 12, 2025Apr 17, 2025Aug 19, 2025Oct 22, 2025Mar 19, 2026Apr 21, 2026Aug 19, 2026
EPS Estimate---------------------0.020.070.05-0.090.06------------------------------------0.300.340.320.260.280.190.29
EPS Actual0.010.020.010.010.010.010.010.010.00-0.020.000.030.000.010.010.120.020.050.040.040.120.130.030.040.040.070.040.030.030.070.050.080.040.070.030.080.060.100.070.080.090.140.130.100.130.230.170.160.180.280.180.160.130.240.190.280.200.310.210.170.210.330.210.140.210.280.120.160.220.23
Surprise---------------------550.00%-57.14%-20.00%--22.22%-33.33%-------------------------------------53.33%-38.24%-12.50%-53.85%-42.86%13.26%-20.69%
Timing---------------------After-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hours-Pre-market-After-hoursAfter-hours-After-hours-Pre-market

Key Statistics & Ratios

Market Cap32.14B
Enterprise Value27.81B
Trailing P/E37.49
Forward P/E0.00
PEG Ratio0.00
Price / Sales3.51
Price / Book4.47
EPS0.74
Book Value5.84
Revenue (TTM)9.16B
Gross Profit (TTM)2.51B
EBITDA1.60B
Profit Margin9.28%
Operating Margin13.12%
Return on Equity12.75%
Return on Assets4.70%
Shares Outstanding1.16B
Shares Float505.68M
Beta0.23
Dividend Yield1.36%
Dividend Rate0.38
Payout Ratio32.82%

Dividends

20261×
0.24Apr 29, 2026
20252×
0.35Sep 17, 20250.36May 22, 2025
20241×
0.32May 23, 2024
20231×
0.30May 22, 2023
20221×
0.28Apr 18, 2022
20211×
0.24Apr 29, 2021
20201×
0.17May 19, 2020
20191×
0.11May 17, 2019
20181×
0.07May 23, 2018
20171×
0.07Jun 26, 2017
20161×
0.06Jun 21, 2016
20151×
0.09Jul 17, 2015
20141×
0.01May 30, 2014
20111×
0.01Jul 19, 2011
20101×
0.01Jul 16, 2010
20091×
0.01Jun 15, 2009
20071×
0.01Jul 5, 2007
20061×
0.01May 30, 2006
20051×
0.01Jun 17, 2005
20041×
0.01Jul 8, 2004
20031×
0.01Nov 18, 2003
19981×
0.03Jul 2, 1998

Stock Splits

  • May 30, 201413:10
  • Jun 21, 20132:1
  • Jul 5, 20071.5:1
  • Feb 15, 200612.5:10
  • May 28, 19991.8:1
  • Jul 2, 199812:10